Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Prostate. 2008 Dec 1;68(16):1806–1815. doi: 10.1002/pros.20848

Figure 3.

Figure 3

A, B, C and D shows Kaplan-Meier curves of nuclear roundness variance, Her-2/neu, CD31 and Ki67 biomarkers for prediction of PCa progression-free survival in patients treated with RP. The Logrank test was used to test the equality of survivor function across the two groups.